Increased Organ Failures and Organ Transplantation to Boost Artificial Vital Organs and Medical Bionics Market to Cross USD 35 Billion by 2020

Artificial Vital Organs and Medical Bionics Market Analysis and Forecast 2013-2020, estimates the global artificial vital organs and medical bionics market to reach nearly USD 35 Billion in 2020, at a CAGR of 7.0% from 2016 to 2020 - iHealthcareAnalyst, Inc.

Visit the Artificial Vital Organs and Medical Bionics Market Analysis and Forecast 2013-2020 report http://www.ihealthcareanalyst.com/report/artificial-vital-organs-medical-bionics-market/

The global artificial vital organs and medical bionics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
The artificial organs are devices implanted or integrated into a human body in order to replace a natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions for the patient to return to a normal life as soon as possible, whereas bionics is the application of biological methods and systems found in nature to the study and design of engineering systems and modern technology.
The global artificial vital organs and medical bionics market segmentation is based on product types (artificial vital organs -artificial heart - total artificial heart, artificial kidney - hemodialysis machines, artificial liver - artificial pancreas, insulin pumps, artificial lungs, heart-lung bypass machines, oxygenators, bionics - ear bionics, vision bionics, exoskeletons, bionic limbs, bionic leg, bionic hand, brain bionics, spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, cardiac bionics, ventricular assist device, left ventricular assist device, right ventricular assist device, heart valves - mechanical heart valves, biological tissue valves, transcatheter heart valves). The global artificial vital organs and medical bionics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global artificial vital organs and medical bionics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Product Type
1.1. Artificial Vital Organs
1.1.1. Artificial Heart
1.1.1.1. Total Artificial Heart (TAH)
1.1.2. Artificial Kidney
1.1.2.1. Hemodialysis Machines
1.1.3. Artificial Liver
1.1.4. Artificial Pancreas
1.1.4.1. Insulin Pumps
1.1.5. Artificial Lungs
1.1.5.1. Heart-Lung Bypass Machines
1.1.5.2. Oxygenators
1.2. Bionics
1.2.1. Ear Bionics (Cochlear Implants)
1.2.2. Vision Bionics
1.2.3. Exoskeletons
1.2.4. Bionic Limbs
1.2.4.1. Bionic Leg
1.2.4.2. Bionic Hand
1.2.5. Brain Bionics
1.2.5.1. Spinal Cord Stimulators
1.2.5.2. Deep Brain Stimulators
1.2.5.3. Vagus Nerve Stimulators
1.2.6. Cardiac Bionics
1.2.7. Ventricular Assist Device (VAD)
1.2.8. Left Ventricular Assist Device (LVAD)
1.2.9. Right Ventricular Assist Device (RVAD)
1.2.10. Heart Valves
1.2.10.1. Mechanical Heart Valves
1.2.10.2. Biological Tissue Valves
1.2.10.3. Transcatheter Heart Valves

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Abbott Diabetes Care, Inc.
3.2. Abiomed, Inc.
3.3. Asahi Kasei Medical Co., Ltd.
3.4. Baxter International, Inc.
3.5. Cyberonics, Inc.
3.6. Edwards Lifesciences Corporation
3.7. Ekso Bionics
3.8. F. Hoffmann-La Roche Ltd
3.9. Fresenius Medical Care AG & Co. Kgaa
3.10. Gambro AB
3.11. Iwalk, Inc.
3.12. Jarvik Heart, Inc.
3.13. Medtronic, Inc.
3.14. Micromed Cardiovascular, Inc.
3.15. Nikkiso Co., Ltd.
3.16. Ossur Hf
3.17. Ottobock Healthcare Gmbh
3.18. Second Sight Medical Products, Inc.
3.19. Syncardia Systems, Inc.
3.20. Thoratec Corporation
3.21. Touch Bionics, Inc.
3.22. Vital Therapies, Inc.
3.23. Worldheart Corporation

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.